Orphan receptors that couple to G protein without known ligands are considered to relate directly to drug discovery. Here, we examine the expression of various orphan receptors in H9c2 cells during ischemic hypoxia and reoxygenation. Among orphan receptors examined, the level of G protein-coupled receptor 41 (GPR41) mRNA increases significantly, with a peak at 2 h after reoxygenation, and recovers to the control level by 3 h after reoxygenation. The level of glyceraldehyde-3-phosphate dehydrogenase mRNA used as an internal control remains almost constant. The levels of c-fos and c-jun mRNA increase significantly with ischemic hypoxia and reoxygenation. The transfection of GPR41 into H9c2 cells results in a significant decrease in cell number, with DNA fragmentation observed by in vitro and in situ assay. The amount of p53 protein increases significantly in the nuclei of cells expressing GPR41, accompanying an increase in the transcriptional activity of p53. Consistent with the activation of p53, the level of bax mRNA is significantly increased, which leads to an increase in Bax protein. Furthermore, the expression of a deletion mutant of a GPR41, which lacks the G protein binding site and shows an attenuation of intracellular phosphorylation signals to H9c2 cells, inhibits cell death and the increase in p53 protein within 24 h after reoxygenation. These observations demonstrate that GPR41 is a novel receptor that activates p53 leading to apoptosis during reoxygenation after ischemic hypoxia in H9c2 cells. We have designated GPR41 as the hypoxia-induced apoptosis receptor, HIA-R.
In response to ischemia and reperfusion, various pathways in mammalian cells are induced, leading to cell death and organ dysfunction. In the heart, prolonged ischemia causes necrosis and contractile dysfunction, but the heart can recover from the injury caused by brief ischemia (1, 2) . During recovery, the expression of various genes is rapidly up-regulated through the activation of transcription factors. Among these transcription factors, the expressions of c-jun and c-fos are regulated by the mitogen-activated protein kinase (MAPK) 1 superfamily (3, 4) . We have shown that during reoxygenation after ischemic hypoxia, an atypical protein kinase C, protein kinase C , which is activated by phosphoinositide 3-kinase (PI3K), participates in the activation of nuclear MAPK (5, 6) . Nuclear MAPK activation can result in the rapid expression of genes during reoxygenation. The gene products induced by ischemia and reperfusion are thought to be involved in the determination of cell fate, such as apoptosis (7) (8) (9) , angiogenesis (10, 11) , and hypertrophy (12) . Among the transcription products, G protein-coupled receptors (GPCR), which transmit signals from the extracellular environment, including neurotransmitters, growth factors, and hormones to the cytoplasm, have been shown to be closely related to the function of tissues exposed to ischemia and reperfusion. Recently, Kobayashi and Millhorn (13) revealed that increased expression of the adenosine A2A receptor, GPCR, during hypoxia, an important aspect of ischemia, protects cells against hypoxia. Another GPCR, adrenomedulin receptor, is up-regulated during hypoxia (14) , leading to the maintenance of the heart by inhibiting the remodeling of heart in response to ligands (15, 16) . Furthermore, Yokomizo and colleagues (17, 18) found a GPCR, the cellsurface receptor for leukotriene B4, that plays a dominant role in reperfusion injury in the kidney.
A large number of orphan receptors that couple to G proteins without known cognate ligands have been identified as the genome project progresses. Recently, we cloned one orphan GPCR, TPRA40, the expression of which is rapidly down-regulated during ischemic hypoxia and reoxygenation (19) . These orphan GPCRs are considered to provide to a fruitful source for drug discovery because 52% of all clinically available medicines act on GPCRs (20) . Since a mutation of the orexin receptor, identified by screening an orphan GPCR, was discovered to cause narcolepsy (21) (22) (23) (24) , much attention has been paid to the relationship between various diseases and orphan receptors. However, the physiological roles and intracellular signaling pathways of many orphan receptors remain unknown. Here, we examined the expression of various orphan receptors by the reverse transcription-polymerase chain reaction (RT-PCR) method using an ischemia and reperfusion cell model isolated in our previous works (5) . Among the orphan receptors examined, post-ischemic reoxygenation markedly induced the expression of G protein-coupled receptor 41 (GPR41) mRNA, an orphan GPCR for which the function has not been reported.
Furthermore, the results obtained here indicate that GPR41 is a novel receptor that activates p53, leading to apoptosis during reoxygenation after ischemic hypoxia.
EXPERIMENTAL PROCEDURES
Materials-Anti-p53 antibody was bought from PharMingen (San Diego, CA). Anti-phospho-p53 antibody (Ser-15) was from New England Biolabs, Inc. (Beverly, MA). Anti-Bax, anti-JNK-1, and anti-phospho-JNK-1 antibodies (Tyr-185) were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-␣-actin antibody was from Sigma. Anti-phosphoSer/Thr/Tyr monoclonal antibody was from CLONTECH Laboratories, Inc. (Palo Alto, CA). Anti-mouse IgG-linked Cy2 was from Amersham Pharmacia Biotech Ltd. (Little Chalfont, Buckinghamshire, UK). A dominant negative mutant of p53 (pCMV-p53mt135) was from CLON-TECH. MilliQ water was used in all experiments (synthesis A10, Millipore, Bedford, MA). All other chemicals were available commercially.
Cell Culture and Ischemic Hypoxia and Reoxygenation-Cell culture and simulated ischemia were achieved as described previously (5) . Briefly, an embryonic rat heart-derived cell line, H9c2 cells, was plated at a density of 5 ϫ 10 4 cells/dish in 100-mm culture dishes. After incubation in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal calf serum for 72 h, the cells were cultured in serum-free DMEM for 60 -72 h and incubated in slightly hypotonic Hanks' balanced saline solution (1.3 mM CaCl 2 , 5 mM KCl, 0.3 mM KH 2 PO 4 , 0.5 mM MgCl 2 , 0.4 mM MgSO 4 , 69 mM NaCl, 4 mM NaHCO 3 , and 0.3 mM NaH 2 PO 4 ) without glucose or serum for 2 h at 37°C. Hypoxia was achieved using an air-tight incubator from which the oxygen was removed by replacement with nitrogen. The oxygen concentration in the incubator was adjusted to 1%. After incubation under the conditions of ischemic hypoxia, the cells were incubated in DMEM without serum under normoxic conditions (20% O 2 , 5% CO 2 ) at 37°C for the indicated times. Human hepatoma cells, HepG2 cells, were also cultured as described above.
RT-PCR Method-RT-PCR was achieved as described previously (19) . Briefly, total RNA was isolated from H9c2 cells using NucleoSpin RNA II kits (CLONTECH. RT was performed with 3 g of total RNA and oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer (Life Technologies, Inc. using SUPERSCRIPT II (Life Technologies, Inc.). The product of the RT reaction was amplified by 35 cycles of PCR using KOD dash (Toyobo, Osaka, Japan) at 94°C for 20 s, 66°C for 2 s, and 74°C for 20 s. The GCCCTTCGCCAT-CATC and TGCTCCGTGCTGTCTG primers were used to observe the expression of GPR41.
Construction and Purification of GPR41 Vectors-Construction and purification of vectors were achieved as described previously (19) . The full-length GPR41 fragment for ligation to the pcDNA3 vector was generated by PCR using a forward primer, TTCTACGGATCCCCATG-GCTGCAACTACTC (P1), containing a BamHI site sequence and a reverse primer, CTAGGAGAATTCTCTCATACAGCACTGCTG (P2), containing an EcoRI site sequence. The full-length GPR41 fragment used for ligation to pGFPC1 vector was generated by PCR using a forward primer, CTACGGAATTCCATGGCTGCAACTACTCCA (P3), containing an EcoRI site sequence and a reverse primer, TAGGAG-GATCCTCTCATACAGCACTGCTGA (P4), containing a BamHI site sequence. The GPR41-⌬154 -375 fragment was generated by PCR using P1 and CGCCGAATTCCTTCAGAAGCTCATCCAGGT (P5), containing an EcoRI site sequence. PCR amplification was performed at a denaturing temperature of 94°C for 20 s, followed by annealing at 70°C for FIG. 1. Expression of GPR41 mRNA during ischemic hypoxia and reoxygenation. Total RNA was extracted from H9c2 cells exposed to ischemic hypoxia and reoxygenation for the indicated times. RT was performed with 3 g total RNA, and the product of the RT reaction was amplified by PCR using the primers for GPR41 (A), G3PDH (B), c-fos (C), and c-jun (C). The RT-PCR products were electrophoresed in agarose gels and stained with ethidium bromide. A-C, representative data obtained from five independent experiments are shown. G3PDH was used as an internal control for equivalent amounts of amplified samples. D, the levels of GPR41 and G3PDH mRNA were determined by densitometric analysis of the electrophoresed bands, and the ratio of the densitometric signal for GPR41 to G3PDH was determined (mean Ϯ S.E., n ϭ 5; *, p Ͻ 0.05 versus control).
FIG. 2. Expression of GPR41 in cells transfected with GPR41.
A, H9c2 cells were pretreated with 4 g of the indicated vectors for 1 h in DMEM containing liposomes. Total RNA was extracted from H9c2 cells at the indicated times. RT was performed with 3 g of total RNA, and the products were amplified by PCR using the primers for GPR41 and G3PDH. The RT-PCR products were electrophoresed in agarose gels and stained with ethidium bromide. The figure shows representative data obtained from three independent experiments. G3PDH was used as an internal control for equivalent amounts of amplified samples. B, total RNA was extracted from the cells exposed to 2 h of reoxygenation after ischemic hypoxia (H2R2) or was extracted from the cells transfected with GPR41. The levels of GPR41 and G3PDH mRNA were determined by densitometric analysis of the electrophoresed bands, and the ratio of the densitometric signal for GPR41 to G3PDH was determined.
2 s and extension at 74°C for 20 s for 35 cycles. The amplified fragments (1150 and 459 base pairs) were separated by electrophoresis on a 2.0% agarose gel. After purification, the cDNA was subcloned into pcDNA3 vector or pGFPC1 vector. The nucleotide sequence was confirmed using a DYEnamic ET terminator sequencing kit (Amersham Pharmacia Biotech) with primers.
Transfection with Vectors into Cells-Transfection of vectors was carried out as described previously (25) . Briefly, cells (typically 80% confluent in 35-mm dishes) were washed three times with phosphatebuffered saline (PBS). Appropriate dilutions of plasmid DNA in 800 l of serum-free DMEM including liposomes (Transfast, Promega, Madison, WI) were preincubated at room temperature for 10 min. The cells were incubated for 1 h at 37°C in the presence of 5% CO 2 . At the end of the incubation period, 4 ml of medium containing 10% fetal bovine serum was added. After incubation for 24 h, the cells were incubated in serum-free medium for 48 -96 h.
Determination of Cell Number-Determination of cell number was carried out as described previously (25) . Cell numbers were determined by a modified MTT assay, the WST-8 assay (Dojindo Chemicals, Inc., Kumamoto, Japan), according to the instruction manual.
Detection of DNA Fragmentation-Total DNA was extracted from cells (typically 80% confluent in 35-mm dishes) using a nucleic acid extraction kit (Apoptosis Ladder Detection Kit, Wako, Osaka, Japan). Electrophoresis of the fragmented DNA was carried out in 1.5% agarose gels in TAE buffer (40 mM Tris, 40 mM acetic acid, 1 mM EDTA, pH 8.0) containing 0.5 g/ml ethidium bromide at 100 V for 30 min. The DNA fragmentation pattern was examined under UV illumination. The in situ labeling assay for DNA fragmentation was performed according to the instruction manual. Briefly, the cells were fixed with 2% paraformaldehyde for 20 min and 0.3% Triton X-100 for 10 min. Following fixation, the cells were incubated with 50 l of TdT solution for 10 min at 37°C and washed with PBS. Endogenous peroxidase was inactivated with 3% H 2 O 2 for 5 min at room temperature and washed with PBS. The cells were incubated with 50 l peroxidase-conjugated antibody solution for 10 min at 37°C, washed with PBS, and then incubated with 3,3Ј-diaminobenzidene solution for 5 min at room temperature.
Electrophoresis and Immunoblotting-Immunoblotting was carried out as described previously (5) . Briefly, cells were washed with cold PBS and lysed with lysis buffer (1% Triton X-100, 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM ␤-glycerol phosphate, 1 mM sodium orthovanadate, 1 g/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride). The cellular extracts and molecular mass standards were electrophoresed in 10% (w/v) polyacrylamide gels in the presence of SDS and transferred to nitrocellulose membranes (0.45 m). The blots were blocked with 5% nonfat dry milk in Tris-buffered saline containing 0.05% Tween 20 and incubated with antibody. After the blots were washed, the antigens were visualized by enhanced chemiluminescent detection reagents.
Immunofluorescent Staining-Immunofluorescent staining was carried out as described previously (5) . Briefly, the cells were fixed with acetone/methanol (50/50) for 3 min at Ϫ20°C. Following fixation, the cells were blocked with 10% fetal bovine serum in PBS for 1 h and then incubated with anti-p53 antibody in PBS containing 3% bovine serum albumin, washed with PBS, and incubated at room temperature with Cy2-conjugated anti-rabbit IgG in PBS containing 3% bovine serum albumin. For Hoechst staining, the cells were fixed with 2% paraformaldehyde for 20 min and treated with 0.3% Triton X-100 for 10 min. Then the cells were incubated with 0.5 mM Hoechst 33258 in PBS and washed with PBS. The cells were viewed under a fluorescence microscope (Axioplan 2, Carl Zeiss Co., Ltd., Heidelberg, Germany).
Luciferase and ␤-Galactosidase Assays-p53-Luciferase vector, pFCp53 expression vector (Stratagene, La Jolla, CA), pCMV-p53mt135, pcDNA3-GPR41 vector, and pSV-␤-galactosidase vector (Promega) were co-transfected as described above. Luciferase activity was determined using the Luciferase Assay System (Promega). Cells were washed with PBS and lysed with lysis buffer 6 h after transfection (Tropix, Bedford, MA). Samples were mixed with luciferase assay rea- . Cell numbers were determined at the indicated times by the WST-8 assay (mean Ϯ S.E., n ϭ 8; *, p Ͻ 0.05 versus empty vector; ϩ, p Ͻ 0.05 versus empty vector ϩ G418). B, total DNA was extracted from untransfected cells (control) and cells transfected with empty vector or GPR41 48 h after transfection as described under "Experimental Procedures." C, the DNAs were electrophoresed in agarose gels in buffer containing ethidium bromide and observed under UV illumination. The in situ DNA fragmentation assay was performed according to the instruction manual as described under "Experimental Procedures." gent, and the luminescence was measured with a luminometer. The ␤-Galactosidase assay was performed according to the instruction manual (␤-Galactosidase Enzyme Assay System, Promega).
RESULTS
Expression of Rat GPR41 mRNA during Ischemic Hypoxia and Reoxygenation-We examined the expression of various orphan receptors in H9c2 cells exposed to ischemic hypoxia and reoxygenation by the RT-PCR method. Among orphan receptors examined, post-ischemic reoxygenation induced the expression of GPR41 mRNA with a peak at 2 h after reoxygenation. The level of mRNA recovered to the control level 3 h after reoxygenation, although the level of GPR41 mRNA remained almost unchanged after 2 h of ischemic hypoxia as shown in Fig. 1, A and D. The amount of mRNA of TPRA40, another GPCR, decreased significantly after 2 h of ischemic hypoxia, and the decrease continued until at least 3 h after reoxygenation (19) . The level of glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA, used as an internal control, remained almost constant throughout ischemic hypoxia and reoxygenation under the conditions used in the study (Fig. 1B) . The expression of the mRNAs of c-fos and c-jun were induced by ischemic hypoxia and reoxygenation (Fig. 1C) , a finding consistent with previous reports (3). To confirm that the cells were exposed to ischemic hypoxia and reoxygenation, we also observed that the level of reactive oxygen species increased during ischemic hypoxia and decreased upon reoxygenation and that the ATP level decreased slightly during ischemic hypoxia and returned to the initial level by reoxygenation.
2 These findings indicate that the expression of GPR41 mRNA increased during reoxygenation following ischemic hypoxia. 
FIG. 7. Transcriptional activity of p53 in cells transfected with GPR41.
A, H9c2 cells were pretreated with a total of 3.5 g of the indicated vectors for 1 h in DMEM containing liposomes. The cells were washed with PBS and lysed with lysis buffer 6 h after transfection. Luciferase activity and ␤-galactosidase activity were determined according to the instruction manuals as described under "Experimental Procedures." The ratio of the luciferase activity to ␤-galactosidase activity was determined (mean Ϯ S.E., n ϭ 3; *, p Ͻ 0.05). B, H9c2 cells were pretreated with 4 g of empty vector (open circles), GPR41 expression vector (open squares), or GPR41 expression vector and expression vector of p53 dominant negative mutant (closed squares) for 1 h in DMEM containing liposomes. Cell numbers were determined at the indicated times by the WST-8 assay (mean Ϯ S.E., n ϭ 8; *, p Ͻ 0.05 versus GPR41 expression vector).
Induction of Apoptosis by GPR41-To clarify the physiological roles of GPR41 induced during reoxygenation after ischemic hypoxia, we transfected the expression vector containing the full-length GPR41 into H9c2 cells and confirmed the expression of GPR41 in the transfected cells by RT-PCR. The transfection of GPR41 into H9c2 cells resulted in the expression of GPR41 after treatment, whereas no GPR41 mRNA was detected in cells transfected with empty vector for up to 48 h under the conditions used in this study (Fig. 2A) . The expression of GPR41 mRNA by transfection was almost similar to that in the cells exposed to reoxygenation after ischemic hypoxia (Fig. 2B) . We transfected pGFP-GPR41 into H9c2 cells to examine the intracellular localization of GPR41. Green fluorescence corresponding to GPR41 was observed on the cell membrane immediately after transfection with GPR41 (Fig. 3B) , and the staining pattern changed to granular from the cell membrane within 24 h after transfection, indicating that the receptor may be internalized (Fig. 3C) . Forty-eight hours after transfection, we observed nuclear condensation, a typical sign of apoptotic cell death, in cells expressing green fluorescence (Fig. 3D) , consistent with the results observed by Hoechst staining (Fig. 3H) . In cells transfected with a control GFP vector, a diffuse cellular pattern of GFP expression was always displayed following the transfection (Fig. 3A) . To examine the relationship between the expression of GPR41 and cell death, we determined cell number following transfection with the GPR41 expression vector. Transfection with GPR41 led to a significant decrease in cell number compared with cells transfected with empty vector 48 h after the removal of serum (Fig.  4A) , although the cell number increased for up to 24 h after transfection due to serum stimulation (Fig. 4A) . Next, to obtain cells stably expressing GPR41, G418 (750 g/ml) was added to the culture medium. In the presence of G418, the number of cells transfected with GPR41 was decreased significantly more compared with cells transfected with empty vector after 48 h of incubation (Fig. 4A) . Untransfected cells did not proliferate for up to 7 days in the presence of G418 (750 g/ml). These findings suggest that the expression of GPR41 enhances cell death after the removal of serum. The same cell death was also observed in HepG2 cells expressing GPR41 (data not shown), suggesting that GPR41-induced cell death may be a common phenomenon in other cell types. To examine whether GPR41-induced cell death is apoptosis, we carried out an in vitro assay of nucleosome ladder formation and an in situ assay of DNA fragmentation by nick labeling, both markers of apoptosis. As shown in Fig. 4B , DNA fragmentation was observed more intensely in cells transfected with GPR41 than in cells transfected with empty vector after 48 h in serum-free DMEM. Consistent with this observation, the number of end-labeled cells increased significantly among cells transfected with GPR41 (Fig. 4C) . Labeled cells were almost undetectable among cells transfected with empty vector (Fig. 4C ). These findings demonstrate that the expression of GPR41 induces apoptosis in H9c2 cells.
Involvement of the p53/Bax Pathway in GPR41-induced Apoptosis-To examine the pathway of apoptosis induced by GPR41, we first observed the expression of p53 mRNA by RT-PCR, because p53 has been reported to induce apoptosis during hypoxia (8) . The expression of p53 mRNA remained almost unchanged in cells transfected with GPR41 for up to 48 h after the removal of serum (Fig. 5A) . The level of G3PDH mRNA, used as an internal control, remained almost constant (Fig. 5A) . Next, we examined the amount of p53 protein after GPR41 transfection by immunoblotting using an anti-p53 antibody. The amount of p53 protein increased significantly immediately after GPR41 transfection (Fig. 5B) . In cells transfected with empty vector, the amount of p53 protein increased slightly upon the removal of serum 48 h after transfection (Fig.  5B) . The amount of ␣-actin, used as an internal control, remained almost constant (Fig. 5B ). These results demonstrate that the stability of the p53 protein is increased by the expression of GPR41. It has been reported that the phosphorylation of several sites in the NH 2 -terminal region of p53 is involved in the stability of the p53 protein (26 -33) . At least the serine phosphorylation of p53 (Ser-15) by an ataxia telangiectasia vectors for 1 h in DMEM containing liposomes. Total RNA was extracted from H9c2 cells at the indicated times. RT was performed with 3 g total RNA, and the product of the RT reaction was amplified by PCR using the primers for Bax and G3PDH. The RT-PCR products were electrophoresed in agarose gels and stained with ethidium bromide. Panel A shows representative data obtained from three independent experiments. B, G3PDH was used as an internal control for equivalent amounts of amplified samples. Cell extracts (40 g of protein) were prepared from H9c2 cells at the indicated times and subjected to immunoblotting with antiBax antibody or anti-␣-actin antibody. Panel B shows representative immunoblots obtained from four independent experiments. mutated kinase activated in response to DNA damage (34, 35) remains almost unchanged after GPR41 transfection (data not shown). It has also been reported that c-Jun NH 2 -terminal kinase (JNK) directly phosphorylates and activates p53 (36 -38) . The tyrosine phosphorylation of JNK1 (Tyr-185) necessary for activation remains almost unchanged in cells transfected with GPR41 and empty vector (data not shown).
We observed the localization of p53 in cells expressing GPR41 by immunocytochemical analysis using an anti-p53 antibody. P53 was localized mainly in the cytosol in the presence of serum (Fig. 6) . After the cells were incubated in serum-free DMEM for 6 h, p53 was found mainly in the nuclei of cells transfected with GPR41, whereas p53 was present exclusively in the cytosol in cells transfected with empty vector 6 h after the removal of serum (Fig. 6) . The staining was inhibited by only secondary antibody (data not shown). These observations indicate that p53 protein accumulates in nuclei in response to the expression of GPR41.
To evaluate the transcriptional activity of p53 in the presence of GPR41, p53-Luc plasmid was co-transfected with GPR41 into H9c2 cells. After co-transfection, we measured the luciferase activity corresponding to the transcriptional activity of p53. We found that the luciferase activity increased significantly in cells transfected with GPR41 compared with cells transfected with empty vector (Fig. 7A) . Luciferase activity was undetectable in cells transfected with empty vectors other than the p53-Luc vector used as a negative control, whereas the luciferase activity was strongly enhanced in cells transfected with the p53 expression vector as a positive control (Fig. 7A) . We then used a dominant negative mutant of p53, in which a guanine at 1017 is replaced by an adenine, to confirm the involvement of p53 in the GPR41-induced cell death. The transfection of the dominant negative mutant of p53 inhibited the increased p53 transcriptional activity by GPR41 below control level (Fig. 7A) . Consistent with the transcriptional activity, cell death by GPR41 was strongly blocked in the cells expressing the dominant negative mutant of p53 (Fig. 7B) . These results show that the transcriptional activity of p53 is enhanced by the transfection of GPR41.
In previous reports, p53 has been shown to be a direct transcriptional activator of the bax gene (39, 40) , a proapoptotic member of the bcl-2 gene family. We examined the expression of bax mRNA following GPR41 transfection and found it to increase significantly immediately after transfection (Fig. 8A) , whereas the level of G3PDH mRNA, used as an internal control, remained almost constant (Fig. 8A) . Consistent with the expression of the mRNA, the amount of Bax protein also increased immediately after GPR41 transfection (Fig. 8B) , whereas the level increased slightly in cells transfected with empty vector followed by weak expression of the bax mRNA (Fig. 8, A and B) , suggesting that p53 may be weakly activated by the removal of serum. The level of ␣-actin, used as an internal control, remained almost constant (Fig. 8B ). These results demonstrate that the Bax protein, a transcriptional product of p53, is induced by GPR41 transfection.
Inhibition of Cell Death by a GPR41 Deletion Mutant-To investigate the involvement of GPR41 in apoptosis during reoxygenation after ischemic hypoxia, we produced a deletion mutant lacking 222 amino acids from the COOH terminus (GPR41-⌬154 -375), because we expected that a GPR41 mutant lacking the G protein binding site would not transduce the signal to intracellular molecules. To confirm the effect of GPR41-⌬154 -375, we examined protein phosphorylation by immunoblotting using an anti-phospho-serine, threonine, and tyrosine antibody. Post-ischemic reoxygenation induces the phosphorylation of protein with a molecular mass of 35 kDa, and the phosphorylation is clearly inhibited by GPR41-⌬154 -375 (Fig. 9A) . The expression of GPR41-⌬154 -375 in H9c2 cells completely inhibited cell death for 24 h after reoxygenation (Fig. 9B) , during which time the increase in the p53 protein was also blocked (Fig. 9C ). These results demonstrate that GPR41 induces apoptosis through the p53/Bax pathway during reoxygenation after ischemic hypoxia. We have designated GPR41 as hypoxia-induced apoptosis receptor (HIA-R).
DISCUSSION
In this study, we demonstrate that the expression of HIA-R mRNA increases during reoxygenation after ischemic hypoxia. The transfection of HIA-R into H9c2 cells leads to a significant decrease in cell number with DNA fragmentation also observed. We also show that the amount of p53 protein increases significantly in the nuclei of cells expressing HIA-R and that the p53 transcriptional activity is enhanced. Consistent with the activation of p53, bax mRNA is significantly induced, which leads to an increase in the amount of Bax protein. Further- more, the expression of a deletion mutant of HIA-R lacking the G protein binding site in H9c2 cells inhibits cell death and the increase in p53 protein within 24 h after reoxygenation.
As shown in this study, the expression of the G proteincoupled receptor HIA-R leads to an accumulation of p53 protein, indicating that HIA-R is a novel receptor present in the upstream region of the p53 pathway. The increase in the p53 protein during HIA-R-induced apoptosis might be due to the stabilization of the p53 protein because the expression of the p53 mRNA remains almost unchanged following HIA-R transfection. Consistent with the increase in the amount of p53 protein and the transcriptional activity of p53, the bax mRNA is also significantly induced. Bax induced by p53 may translocate to mitochondria, causing a release of cytochrome c through the mitochondrial porin channel (41) (42) (43) (44) and leading finally to apoptosis in the HIA-R pathway. p53 has been reported to be phosphorylated on several serine residues by different kinases in response to various stresses (26 -33) . Under the conditions used in this study, p53 phosphorylation on serine 15, the phosphorylation site of an ataxia telangiectasia mutated kinase in response to DNA damage (34, 35) , remained undetected following HIA-R transfection. The phosphorylation of JNK1 necessary for the activation also remained unchanged after HIA-R transfection, although MEKK/JNK signaling stabilizes and activates p53 (36 -38) .
HIA-R might play a role in the induction of apoptosis during reoxygenation after ischemic hypoxia for the following reasons. First, HIA-R mRNA was induced during reoxygenation after ischemic hypoxia, when apoptosis was observed in H9c2 cells, but not during ischemic hypoxia in which apoptosis is undetectable. Second, the expression of HIA-R in H9c2 cells leads to apoptotic cell death through p53 activation as described above.
Finally, HIA-R shows a high (81%) amino acid sequence identity to the human interleukin-8-related receptor, DRY12 (GenBank TM accession number U58828) (45) . Recently, it was reported that hypoxia induces the expression of interleukin-8 (46) , which results in apoptosis (47) . To confirm that HIA-R participates in apoptosis during reoxygenation following ischemic hypoxia, we produced a deletion mutant of HIA-R lacking the COOH-terminal 222 amino acids, including the second inner loop, and speculated that the mutant of HIA-R would not transmit the extracellular stimulation to intracellular pathway although it can bind to the ligand. Because it has been reported that the NH 2 -terminal domain of the interleukin-8 receptor, which shows identity with HIA-R, is the binding site for the ligand (48 -53) , and the second inner loop is sufficient for intracellular signaling through the G protein (54) . Transfection of the COOH-terminal deletion mutant of HIA-R inhibits cell death during reoxygenation after ischemic hypoxia, and the increase in p53 protein is also blocked. How is the stability of the p53 protein during HIA-R-induced apoptosis following ischemic hypoxia and reoxygenation regulated? PI3K may be involved in the phosphorylation of p53 during HIA-R-induced apoptosis, because it has been reported that an inhibitor of PI3K, LY294002, inhibits the phosphorylation of p53 (55) and that PI3K is activated in response to a G protein-coupled receptor (56 -58) . We have also provided evidence implicating PI3K in cell death induced by hypoxia, as well as in cell survival. 3 Recent studies have shown that apoptotic cell death occurs in cardiomyocytes exposed to ischemia and reperfusion (59 -61) . The loss of cardiomyocytes by apoptosis is known to play a role in the development of cardiac failure due to ischemia and reperfusion (62, 63) because cardiomyocytes are terminally differentiated and cannot proliferate. Despite convincing evidence that apoptosis occurs in cardiomyocytes during ischemia and reperfusion, the mechanism and signaling pathway that lead to apoptotic cell death have been poorly elucidated to date. We have described a novel receptor of apoptosis during reoxygenation after ischemic hypoxia, and it is possible that the inhibition of HIA-R could lead to the maintenance of cardiac function following coronary artery occlusion. Further studies are required to elucidate the role of HIA-R after ischemic hypoxia.
